DermTech Debt to Equity Ratio 2017-2024 | DMTKQ
Current and historical debt to equity ratio values for DermTech (DMTKQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. DermTech debt/equity for the three months ending March 31, 2024 was 0.00.
| DermTech Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $0.06B | $0.04B | 1.58 |
| 2023-12-31 | $0.07B | $0.06B | 1.13 |
| 2023-09-30 | $0.07B | $0.07B | 0.89 |
| 2023-06-30 | $0.07B | $0.09B | 0.78 |
| 2023-03-31 | $0.07B | $0.11B | 0.65 |
| 2022-12-31 | $0.07B | $0.13B | 0.53 |
| 2022-09-30 | $0.04B | $0.16B | 0.25 |
| 2022-06-30 | $0.04B | $0.18B | 0.21 |
| 2022-03-31 | $0.04B | $0.20B | 0.18 |
| 2021-12-31 | $0.02B | $0.23B | 0.08 |
| 2021-09-30 | $0.02B | $0.25B | 0.07 |
| 2021-06-30 | $0.01B | $0.27B | 0.03 |
| 2021-03-31 | $0.01B | $0.26B | 0.03 |
| 2020-12-31 | $0.01B | $0.06B | 0.13 |
| 2020-09-30 | $0.01B | $0.05B | 0.09 |
| 2020-06-30 | $0.01B | $0.06B | 0.10 |
| 2020-03-31 | $0.01B | $0.07B | 0.08 |
| 2019-12-31 | $0.01B | $0.01B | 0.46 |
| 2019-09-30 | $0.01B | $0.02B | 0.27 |
| 2019-06-30 | $0.01B | $0.01B | 1.50 |
| 2019-03-31 | $0.01B | $0.01B | 1.49 |
| 2018-12-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.14B | $0.01B | 28.59 |
| 2018-06-30 | $0.01B | $0.14B | 0.06 |
| 2018-03-31 | $0.14B | $0.01B | 28.38 |
| 2017-12-31 | $0.14B | $0.01B | 28.30 |
| 2017-09-30 | $0.14B | $0.01B | 28.25 |
| 2017-06-30 | $0.14B | $0.01B | 28.20 |
| 2017-03-31 | $0.00B | $0.00B | 7.77 |
| 2016-12-31 | $0.00B | $0.00B | 0.00 |
| 2016-09-30 | $0.00B | $0.00B | 0.00 |
| 2016-06-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.015B |
| DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.938B | 15.80 |
| Cencora (COR) | United States | $44.936B | 17.52 |
| ICON (ICLR) | Ireland | $25.860B | 24.41 |
| DiDi Global (DIDIY) | China | $20.122B | 0.00 |
| CochLear (CHEOY) | Australia | $14.423B | 0.00 |
| Avantor (AVTR) | United States | $14.400B | 21.20 |
| Natera (NTRA) | United States | $13.298B | 0.00 |
| Revvity (RVTY) | United States | $12.939B | 22.70 |
| Medpace Holdings (MEDP) | United States | $12.761B | 41.98 |
| Viatris (VTRS) | United States | $12.657B | 3.78 |
| Charles River Laboratories (CRL) | United States | $10.641B | 20.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.412B | 0.00 |
| Solventum (SOLV) | United States | $9.133B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.426B | 0.00 |
| HealthEquity (HQY) | United States | $7.500B | 48.16 |
| Organon (OGN) | United States | $5.323B | 5.05 |
| Doximity (DOCS) | United States | $5.186B | 36.33 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 20.45 |
| PACS (PACS) | United States | $4.496B | 0.00 |
| Life Times (LTH) | United States | $3.744B | 39.23 |
| Sotera Health (SHC) | United States | $3.360B | 16.49 |
| Surgery Partners (SGRY) | United States | $3.024B | 27.66 |
| GoodRx Holdings (GDRX) | United States | $2.927B | 111.43 |
| Progyny (PGNY) | United States | $2.724B | 46.90 |
| Agilon Health (AGL) | United States | $2.690B | 0.00 |
| Premier (PINC) | United States | $1.957B | 8.37 |
| AMN Healthcare Services Inc (AMN) | United States | $1.947B | 7.72 |
| BrightSpring Health Services (BTSG) | United States | $1.946B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.659B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.495B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.250B | 0.00 | |
| CareDx (CDNA) | United States | $0.809B | 0.00 |
| Embecta (EMBC) | United States | $0.721B | 4.90 |
| GeneDx Holdings (WGS) | United States | $0.683B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.675B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.635B | 6.74 |
| Auna S.A (AUNA) | Luxembourg | $0.591B | 0.00 |
| Sharecare (SHCR) | United States | $0.489B | 0.00 |
| Enhabit (EHAB) | United States | $0.447B | 44.60 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.413B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.381B | 0.00 |
| ModivCare (MODV) | United States | $0.373B | 6.98 |
| QDM (QDMI) | Hong Kong, SAR China | $0.353B | 9.24 |
| DocGo (DCGO) | United States | $0.314B | 17.17 |
| LifeMD (LFMD) | United States | $0.285B | 0.00 |
| MultiPlan (MPLN) | United States | $0.250B | 0.00 |
| Beauty Health (SKIN) | United States | $0.237B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.194B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.193B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| So-Young (SY) | China | $0.110B | 53.25 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.045B | 6.04 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Oncology Institute (TOI) | United States | $0.034B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.023B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.022B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.021B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.016B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |